[{"NetIncomeLoss_1_Q3_USD":-38528000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":360540000.0,"Liabilities_0_Q3_USD":610966000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-3000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-6000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":-20722000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"MarketableSecuritiesCurrent_0_Q3_USD":108167000.0,"InventoryGross_0_Q3_USD":83940000.0,"DepreciationAndAmortization_1_Q3_USD":900000.0,"DepreciationAndAmortization_3_Q3_USD":2618000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":45826000.0,"InventoryFinishedGoods_0_Q3_USD":31698000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-273000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":440000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_Q3_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-245900000.0,"PurchaseObligation_0_Q3_USD":64560000.0,"ProvisionForLoanLossesExpensed_1_Q3_USD":0.0,"ProvisionForLoanLossesExpensed_3_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":673039000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":119661000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":39925000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":45487000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":21280000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":38076739.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":37875696.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1288000.0,"OtherAssetsNoncurrent_0_Q3_USD":10262000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q3_USD":19042000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-2936000.0,"ConvertibleNotesPayableCurrent_0_Q3_USD":80978000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-38534000.0,"LongTermLoansPayable_0_Q3_USD":57924000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":312343000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":54085000.0,"GainLossOnContractTermination_3_Q3_USD":-3210000.0,"InventoryRawMaterials_0_Q3_USD":5617000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":2884000.0,"EarningsPerShareBasic_1_Q3_USD":-0.49,"EarningsPerShareBasic_3_Q3_USD":-3.22,"InventoryWriteDown_3_Q3_USD":5192000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":74984811.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":79013240.0,"PurchaseObligationDueInSecondYear_0_Q3_USD":9753000.0,"LoansPayableCurrent_0_Q3_USD":17308000.0,"CommonStockSharesIssued_0_Q3_shares":76583279.0,"ProceedsFromStockPlans_3_Q3_USD":1985000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":30000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"PurchaseObligationDueInNextTwelveMonths_0_Q3_USD":34606000.0,"CommonStockValue_0_Q3_USD":7000.0,"NetIncomeLossAttributableToParentDiluted_3_Q3_USD":-241375000.0,"NetIncomeLossAttributableToParentDiluted_1_Q3_USD":-38528000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":50392000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q3_USD":27547000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"CostsAndExpenses_3_Q3_USD":477491000.0,"CostsAndExpenses_1_Q3_USD":115290000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":62700000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":102000.0,"Assets_0_Q3_USD":741726000.0,"ShareBasedCompensation_3_Q3_USD":40418000.0,"InterestExpenseRelatedParty_3_Q3_USD":1902000.0,"Goodwill_0_Q3_USD":943000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-241375000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-38528000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1730000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":11786000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":0.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-6000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":14890000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":74984811.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":79013240.0,"InventoryWorkInProcess_0_Q3_USD":46625000.0,"LiabilitiesCurrent_0_Q3_USD":320348000.0,"AccountsPayableCurrent_0_Q3_USD":45707000.0,"InterestExpense_3_Q3_USD":17166000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":171779000.0,"InterestExpense_1_Q3_USD":5771000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":10025000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":9726000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":9870000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":2620000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_security":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":74984811.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":79013240.0,"AdditionalPaidInCapital_0_Q3_USD":1135155000.0,"ConvertibleSubordinatedDebtNoncurrent_0_Q3_USD":223971000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"InventoryNoncurrent_0_Q3_USD":46357000.0,"ReceivablesNetCurrent_0_Q3_USD":136346000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-492000.0,"NetIncomeLoss_3_Q3_USD":-241375000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":360980000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-241378000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-3.22,"InterestExpenseRelatedParty_1_Q3_USD":637000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":40903000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q3_USD":8505000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4590000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":30495000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"OperatingIncomeLoss_3_Q3_USD":-224311000.0,"OperatingIncomeLoss_1_Q3_USD":-32787000.0,"InventoryNet_0_Q3_USD":37583000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":741726000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":18793000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.49,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":477000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":16526000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":434000.0,"ProfitLoss_3_Q3_USD":-241375000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":750000.0,"StockholdersEquity_0_Q3_USD":130760000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":16760000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":821000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-909000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":253180000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":82503000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1004129000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-180618000.0,"CommonStockSharesOutstanding_0_Q3_shares":76583279.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":3150000.0,"PurchaseObligationDueInThirdYear_0_Q3_USD":3441000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]